DK1146863T3 - Lyofilisater med forbedret rekonstituerbarhed - Google Patents

Lyofilisater med forbedret rekonstituerbarhed

Info

Publication number
DK1146863T3
DK1146863T3 DK00906226T DK00906226T DK1146863T3 DK 1146863 T3 DK1146863 T3 DK 1146863T3 DK 00906226 T DK00906226 T DK 00906226T DK 00906226 T DK00906226 T DK 00906226T DK 1146863 T3 DK1146863 T3 DK 1146863T3
Authority
DK
Denmark
Prior art keywords
lyophilisates
improved
reconstitutability
improved reconstitutability
reconstituted
Prior art date
Application number
DK00906226T
Other languages
Danish (da)
English (en)
Inventor
Thekla Kurz
Ludwig Krueger
Brigitte Hesse
Arnd Karnatz
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK1146863T3 publication Critical patent/DK1146863T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat
    • F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
    • F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Steroid Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Waveguide Aerials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK00906226T 1999-01-28 2000-01-26 Lyofilisater med forbedret rekonstituerbarhed DK1146863T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19903275A DE19903275A1 (de) 1999-01-28 1999-01-28 Lyophilisate mit verbesserter Rekonstituierbarkeit
PCT/EP2000/000569 WO2000044354A1 (de) 1999-01-28 2000-01-26 Lyophilisate mit verbesserter rekonstituierbarkeit

Publications (1)

Publication Number Publication Date
DK1146863T3 true DK1146863T3 (da) 2004-08-30

Family

ID=7895601

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00906226T DK1146863T3 (da) 1999-01-28 2000-01-26 Lyofilisater med forbedret rekonstituerbarhed

Country Status (21)

Country Link
US (1) US6770678B1 (enExample)
EP (1) EP1146863B1 (enExample)
JP (2) JP4562288B2 (enExample)
KR (1) KR20010108136A (enExample)
AT (1) ATE266387T1 (enExample)
AU (1) AU757781B2 (enExample)
BR (1) BRPI0007714B8 (enExample)
CA (1) CA2361237C (enExample)
CZ (1) CZ20012693A3 (enExample)
DE (2) DE19903275A1 (enExample)
DK (1) DK1146863T3 (enExample)
ES (1) ES2220404T3 (enExample)
HU (1) HU226585B1 (enExample)
NO (1) NO331321B1 (enExample)
PL (1) PL351140A1 (enExample)
PT (1) PT1146863E (enExample)
RU (1) RU2225709C2 (enExample)
SK (1) SK10542001A3 (enExample)
UA (1) UA70351C2 (enExample)
WO (1) WO2000044354A1 (enExample)
ZA (1) ZA200107081B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2471144C (en) 2002-01-09 2011-06-07 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
DE102004045825A1 (de) * 2004-09-22 2006-03-23 Merck Patent Gmbh Lyophilisat enthaltend N-Diaminomethylen-2-methyl-4,5-di-(methylsulfonyl)-benzamid
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
RU2299063C1 (ru) * 2006-03-03 2007-05-20 Федеральное государственное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии имени Г.Н. Габричевского Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" (ФГУН МНИИЭМ им. Г.Н. Габричевского Роспотребнадзора) Способ сушки термолабильного биологически активного препарата
DK2271327T3 (en) 2008-05-09 2015-07-13 Merck Patent Gmbh Pharmaceutical composition comprising rhymeporide for the treatment of diseases associated with beta-cell dysfunction
US8183267B2 (en) * 2008-06-09 2012-05-22 Awd. Pharma Gmbh & Co. Kg Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
US10584123B2 (en) * 2017-09-27 2020-03-10 Fedora Pharmaceuticals Inc. Pharmaceutical forms of diazabicyclooctane derivatives and manufacturing method thereof
EP3733182A4 (en) * 2017-12-28 2021-09-01 FUJIFILM Toyama Chemical Co., Ltd. PROCESS FOR PREPARING A FREEZE-DRIED FORMULATION

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002748A (en) 1976-01-19 1977-01-11 Eli Lilly And Company Method of preparing sterile essentially amorphous cefazolin for reconstitution for parenteral administration
JPH07114946B2 (ja) * 1988-10-24 1995-12-13 株式会社奈良機械製作所 難溶性物質の処理方法
US5066647A (en) * 1989-04-20 1991-11-19 Erbamont, Inc. Cyclophosphamide - alanine lyophilizates
DK0589336T3 (da) * 1992-09-22 1997-06-16 Hoechst Ag Benzylguanidiner, fremgangsmåde til deres fremstilling samt deres anvendelse som antiarytmetika
JP2747967B2 (ja) 1993-07-23 1998-05-06 雪印乳業株式会社 シアル酸粉末
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
RU2105569C1 (ru) * 1995-06-05 1998-02-27 Индивидуальное частное предприятие Фирма "Брынцалов" Способ получения лекарственной формы противоопухолевого антибиотика
DE19529612A1 (de) * 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate
RU2111426C1 (ru) * 1995-11-03 1998-05-20 Государственный научный центр вирусологии и биотехнологии "Вектор" Способ лиофильной сушки биопрепарата
JPH09183729A (ja) * 1995-12-29 1997-07-15 Meiji Milk Prod Co Ltd 凍結乾燥ウラシルを含有する抗腫瘍医薬組成物

Also Published As

Publication number Publication date
ZA200107081B (en) 2003-02-26
NO20013703D0 (no) 2001-07-27
PL351140A1 (en) 2003-03-24
HUP0105493A3 (en) 2006-07-28
KR20010108136A (ko) 2001-12-07
HUP0105493A2 (en) 2002-06-29
BR0007714A (pt) 2001-11-27
JP2002535089A (ja) 2002-10-22
RU2225709C2 (ru) 2004-03-20
CA2361237C (en) 2008-07-15
ATE266387T1 (de) 2004-05-15
BRPI0007714B8 (pt) 2021-05-25
EP1146863B1 (de) 2004-05-12
US6770678B1 (en) 2004-08-03
HU226585B1 (en) 2009-04-28
AU2798600A (en) 2000-08-18
ES2220404T3 (es) 2004-12-16
EP1146863A1 (de) 2001-10-24
DE50006404D1 (de) 2004-06-17
JP4562288B2 (ja) 2010-10-13
JP2010264249A (ja) 2010-11-25
SK10542001A3 (sk) 2002-01-07
NO331321B1 (no) 2011-11-21
NO20013703L (no) 2001-07-27
CZ20012693A3 (cs) 2002-01-16
PT1146863E (pt) 2004-10-29
CA2361237A1 (en) 2000-08-03
WO2000044354A1 (de) 2000-08-03
DE19903275A1 (de) 2000-08-03
AU757781B2 (en) 2003-03-06
UA70351C2 (en) 2004-10-15
BR0007714B1 (pt) 2014-09-30

Similar Documents

Publication Publication Date Title
AP1771A (en) 3'-Prodrugs of 2'-deoxy-?-L-nucleosides.
NO20025893D0 (no) Veksthormon sekretagoga
NO20013341D0 (no) Fenylfenantridiner med PDE-IV inhiberende aktivitet
ATE244241T1 (de) Hemmung der menschlichen telomerase durch g- quadruplex interaktionverbindung
DK1146863T3 (da) Lyofilisater med forbedret rekonstituerbarhed
DE60131811D1 (de) Heteroübergangsbipolartransistor
DK1066291T3 (da) Svampedræbende 6-(2-halogen-4-alkoxyphenyl)-triazolopyrimidiner
DE60033918D1 (de) Polysubstituted 6-phenylphenanthridines mit pde-iv hemmender wirkung
BRPI0415382A (pt) disposição para fixação de um transmissor de calor em um outro transmissor de calor
DE60019894D1 (de) Phenantrhridin-n-oxides mit pde-iv hemmender wirkung
DK1254118T3 (da) Substituerede 1,2,3,4-tetrahudroquinolin-2-carboxylsyrederivater
ATE317396T1 (de) 14,15-beta-methylen substituierte androgene
ATE342957T1 (de) Waschmittelformkörper mit viskoelastischer phase
DK1023903T3 (da) Anvendelse af levende, svækkede bakterier til fremstilling af en submukös vaccine
ATE344272T1 (de) Uridinderivate als antibiotika
DK1180041T3 (da) Vaccine med ISA-virus
ITMI20001498A0 (it) Dispositivo per l'allineamento, con disposizione rettilinea dei bordi, di pachetti di pezzi in lavorazione rettangolari piatti.
DK1459751T3 (da) (S,S)reboxetin til behandling af migrænehovedpine
DE60135552D1 (de) Selbstkonfigurierbare verstärkerschaltung
BR8303419U (pt) Desarme automático com regulagem fixa em implementos agrìcolas
DK1068783T3 (da) Centrifugalspreder med to skiver
Sankaran Sankaran
윤인진 Caught in the Middle Korean Merchants in America's Multiethnic Cities
IT1317507B1 (it) Dispositivo per l'applicazione di cravatte, particolarmente perfacilitare la realizzazione del nodo della cravatta.
IT249633Y1 (it) Moletta per stendere panni.